Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Virtual docking screening and quantitative structure-activity relationship studies to explore AKT and PI3K inhibitors acting on mTOR in cancers by theoretical biology and medical modeling.
Kandoussi I, Abbou H, Haddoumi GE, Mansouri M, Belyamani L, Ibrahimi A. Kandoussi I, et al. Among authors: ibrahimi a. Contemp Oncol (Pozn). 2023;27(3):155-162. doi: 10.5114/wo.2023.133709. Epub 2023 Dec 13. Contemp Oncol (Pozn). 2023. PMID: 38239868 Free PMC article.
In Silico Analyses of All STAT3 Missense Variants Leading to Explore Divergent AD-HIES Clinical Phenotypes.
Mansouri M, El Haddoumi G, Bendani H, Boumajdi N, Hakmi M, Abbou H, Bouricha EM, Elgharbaoui B, Kartti S, El Jaoudi R, Belyamani L, Kandoussi I, Ibrahimi A, El Hafidi N. Mansouri M, et al. Among authors: ibrahimi a. Evol Bioinform Online. 2023 Apr 24;19:11769343231169374. doi: 10.1177/11769343231169374. eCollection 2023. Evol Bioinform Online. 2023. PMID: 37123531 Free PMC article.
Selective Non-toxics Inhibitors Targeting DHFR for Tuberculosis and Cancer Therapy: Pharmacophore Generation and Molecular Dynamics Simulation.
Haddoumi GE, Mansouri M, Bendani H, Chemao-Elfihri MW, Kourou J, Abbou H, Belyamani L, Kandoussi I, Ibrahimi A. Haddoumi GE, et al. Among authors: ibrahimi a. Bioinform Biol Insights. 2023 May 8;17:11779322231171778. doi: 10.1177/11779322231171778. eCollection 2023. Bioinform Biol Insights. 2023. PMID: 37180813 Free PMC article.
Overcoming Resistance in Cancer Therapy: Computational Exploration of PIK3CA Mutations, Unveiling Novel Non-Toxic Inhibitors, and Molecular Insights Into Targeting PI3Kα.
Kandoussi I, El Haddoumi G, Mansouri M, Belyamani L, Ibrahimi A, Eljaoudi R. Kandoussi I, et al. Among authors: ibrahimi a. Bioinform Biol Insights. 2024 Aug 19;18:11779322241269386. doi: 10.1177/11779322241269386. eCollection 2024. Bioinform Biol Insights. 2024. PMID: 39176270 Free PMC article.
291 results